Inhibition of dengue virus entry into target cells using synthetic antiviral peptides

International Journal of Medical Sciences

Volumn 10, Issue 6, 2013, Pages 719-729

  Alhoot, Mohammed Abdelfatah ^a,b   Rathinam, Alwin Kumar ^a   Wang, Seok Mui ^c   Manikam, Rishya ^d   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MANAGEMENT AND SCIENCE UNIVERSITY   (Malaysia)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^d UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Antiviral peptides; Dengue virus; Domain III; Envelope protein; Inhibitory peptides; Viral entry

Indexed keywords

ANTIVIRUS AGENT; DET1 PEPTIDE; DET2 PEPTIDE; DET3 PEPTIDE; DET4 PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; DENGUE VIRUS 2; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; TARGET CELL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION; VIRUS PLAQUE; WESTERN BLOTTING;

ANTIVIRAL PEPTIDES; DENGUE VIRUS; DOMAIN III; ENVELOPE PROTEIN; INHIBITORY PEPTIDES; VIRAL ENTRY;

ANTIVIRAL AGENTS; DENGUE; DENGUE VIRUS; HUMANS; PEPTIDES; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84876423396     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5037     Document Type: Article

References (42)

1. Chen Y, Maguire T, Marks RM. Demonstration of binding of dengue virus envelope protein to target cells. J Virol. 1996; 70: 8765-72.
2. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002; 108: 717-25.
3. Clyde K, Kyle JL, Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol. 2006; 80: 11418-31.
4. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004; 427: 313-9.
5. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends in microbiology. 2000; 8: 402-10.
6. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clinical Microbiology Reviews. 2006; 19: 491-511.
7. Benincasa M, Skerlavaj B, Gennaro R, Pellegrini A, Zanetti M. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides. 2003; 24: 1723-31.
8. Albiol Matanic VC, Castilla V. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int J Antimicrob Agents. 2004; 23: 382-9.
9. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. Journal of virology. 2004; 78: 5147-56.
10. Yasin B, Pang M, Turner JS, Cho Y, Dinh NN, Waring AJ, et al. Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis. 2000; 19: 187-94.
11. Hrobowski YM, Garry RF, Michael SF. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J. 2005; 2: 49.
12. Schmidt AG, Yang PL, Harrison SC. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog. 2010; 6: e1000851.
13. Das S, Garver L, Ramirez JR, Xi Z, Dimopoulos G. Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination. J Vis Exp. 2007;: e220.
14. De Madrid AT, Porterfield JS. A simple micro-culture method for the study of group B arboviruses. Bulletin of the World Health Organization. 1969; 40: 113.
15. Hung JJ, Hsieh MT, Young MJ, Kao CL, King CC, Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. Journal of virology. 2004; 78: 378-88.
16. Mazumder R, Hu ZZ, Vinayaka CR, Sagripanti JL, Frost SD, Kosakovsky Pond SL, et al. Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines. Virus Genes. 2007; 35: 175-86.
17. Biro JC. Amino acid size, charge, hydropathy indices and matrices for protein structure analysis. Theoretical biology & medical modelling. 2006; 3: 15.
18. Yang JM, Chen YF, Tu YY, Yen KR, Yang YL. Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One. 2007; 2: e428.
19. Kong YY, Thay CH, Tin TC, Devi S. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. Journal of Virological Methods. 2006; 138: 123-30.
20. Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochemical and Biophysical Research Communications. 2007; 353: 882-8.
21. Ng TI, Mo H, Pilot-Matias T, He Y, Koev G, Krishnan P, et al. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology. 2007; 45: 1413-21.
22. Paeshuyse J, Kaul A, De Clercq E, Rosenwirth B, Dumont JM, Scalfaro P, et al. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology. 2006; 43: 761-70.
23. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature. 2008; 455: 242-5.
24. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, et al. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol. 2010; 84: 2490-501.
25. Alhoot MA, Wang SM, Sekaran SD. Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference. PLoS Negl Trop Dis. 2011; 5: e1410.
26. Alhoot MA, Wang SM, Sekaran SD. RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells. PLoS One. 2012; 7: e34060.
27. Bai F, Town T, Pradhan D, et al. Antiviral peptides targeting the west nile virus envelope protein. J Virol. 2007; 81: 2047-55.
28. Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, et al. Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis. 2010; 4: e721.
29. Unal EB, Gursoy A, Erman B. VitAL: Viterbi algorithm for de novo peptide design. PLoS One. 2010; 5: e10926.
30. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, et al. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 2004; 23: 728-38.
31. Ying C, De Clercq E, Neyts J. Selective Inhibition of Hepatitis B Virus Replication by RNA Interference. Biochemical and Biophysical Research Communications. 2003; 309: 482-4.
32. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, et al. Inhibition of Hepatitis B Virus in Mice by RNA Interference. Nature biotechnology. 2003; 21: 639-44.
33. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. Small Interfering RNA Inhibits Hepatitis B Virus Replication in Mice. Molecular Therapy. 2003; 8: 769-76.
34. Huang ES, Samudrala R, Park BH. Scoring functions for ab initio protein structure prediction. Methods Mol Biol. 2000; 143: 223-45.
35. Samudrala R, Moult J. An all-atom distance-dependent conditional probability discriminatory function for protein structure prediction. J Mol Biol. 1998; 275: 895-916.
36. Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nature structural & molecular biology. 2008; 15: 312-7.
37. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, Ramos C, et al. Dengue virus structural differences that correlate with pathogenesis. Journal of virology. 1999; 73: 4738.
38. Mandl CW, Kroschewski H, Allison SL, Kofler R, Holzmann H, Meixner T, et al. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. Journal of virology. 2001; 75: 5627-37.
39. Sánchez IJ, Ruiz BH. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. Journal of general virology. 1996; 77: 2541.
40. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997; 3: 866-71.
41. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001; 166: 1499-506.
42. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003; 305: 330-8.